VALN
Valneva SE
NASDAQ · Healthcare · Biotechnology · FR
$6.89
−2.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 10.46x
- P/E 2028E
- 19.21x
- P/S forward
- 3.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.93x
- Price / sales
- 3.92x
- Price / cash flow
- -6.76x
Enterprise value
- Enterprise value
- $756.4M
- EV / sales
- 4.53x
- EV / EBITDA
- -6.90x
- EV / EBIT
- -5.60x
- Market cap
- $653.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026